Trial Profile
Clinical Trials Insight: 700036482
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 21 Aug 2008
Price :
$35
*
At a glance
- Drugs Naproxen etemesil (Primary)
- Indications Inflammation; Musculoskeletal pain; Osteoarthritis; Pain; Rheumatoid arthritis
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Logical Therapeutics
- 21 Aug 2008 New trial record.
- 18 Aug 2008 Results reported in a Logical Therapeutics media release.